Efficacy of the monocarbonyl curcumin analog C66 in the reduction of diabetes-associated cardiovascular and kidney complications
Abstract Curcumin is a polyphenolic compound derived from turmeric that has potential beneficial properties for cardiovascular and renal diseases and is relatively safe and inexpensive. However, the application of curcumin is rather problematic due to its chemical instability and low bioavailability...
Saved in:
Main Authors: | Mitko Mladenov (Author), Jane Bogdanov (Author), Bogdan Bogdanov (Author), Nikola Hadzi-Petrushev (Author), Andre Kamkin (Author), Radoslav Stojchevski (Author), Dimiter Avtanski (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GLUT5-overexpression-related tumorigenic implications
by: Nikola Hadzi-Petrushev, et al.
Published: (2024) -
Discovery and evaluation of asymmetrical monocarbonyl analogs of curcumin as anti-inflammatory agents
by: Zhang Y, et al.
Published: (2014) -
Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease's Statin Therapy in Men
by: Nikola Hadzi-Petrushev, et al.
Published: (2018) -
Correction of mitochondrial dysfunction with trimethoxy-substituted monocarbonyl curcumin analogues in experimental Alzheimer's disease
by: D. I. Pozdnyakov, et al.
Published: (2024) -
Design, synthesis, and evaluation of cyclic C7-bridged monocarbonyl curcumin analogs containing an o-methoxy phenyl group as potential agents against gastric cancer
by: Xin Gan, et al.
Published: (2024)